- Quote, Chart, News
- Snapshot
- Company Report
- Quotes
- Charts
- Key Developments
Recent News- Research
- SEC Filings
- Advisor FYI
- CAPS
- StockScouter
- Earnings Estimates
- Analyst Ratings
- Financial Results
- Insider Trading
- Ownership
- Message Board
- Guided Research
- Research Wizard
- Find Stocks
- Stock Screener
- Stock Power Searches
- Top-Rated Stocks
- Related Links
- Quote Watchlist
- Expert Picks
- E-mail & Alerts
- IPO Center
- Message Boards
- Capital Gains Analysis
News resources
| American International Group Inc (AIG) | 2 stories... |
| Incyte Corp (INCY) | 2 stories... |
| Goldman Sachs Group Inc (GS) | 2 stories... |
| Microsoft Corp (MSFT) | 2 stories... |
| Washington Post Co (WPO) | 2 stories... |
| advertisement |
Mylan Ord Shs: All Recent News
- 'Fast Money' Recap: Turkey Trades 11/20/2009
- The trading panel discussed what trades they would make during a holiday-shortened week. At TheStreet.com
- Pfizer's Generic Growth, With a Side of Sashimi 11/19/2009
- A move into Japan isn't a bad idea, but it isn't going to save the company either. At Motley Fool
- Mylan's President of Europe, Middle East and Africa Elected... 11/18/2009
- PITTSBURGH, Nov. 18 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that Didier Barret, president of Mylan Europe, Middle East and Africa (EMEA), has been elected president of the... PR Newswire
- The Life-and-Death Situation That Isn't 11/12/2009
- Branded-drug makers aren't playing fair. At Motley Fool
- Mylan's Spanish Business Named Best Generic Pharmaceuticals... 11/12/2009
- PITTSBURGH, Nov. 12 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan SA has received the prestigious 2009 Elsevier Galien Award for Best Generics Company... PR Newswire
- Mylan gets FDA approval for generic Prevacid 11/10/2009
- PITTSBURGH (AP) - Mylan Inc. said Tuesday the Food and Drug Administration approved its generic version of the heartburn drug Prevacid. Associated Press
- Market Report -- In Play (MYL) 11/10/2009
- Mylan Labs receives FDA approval for generic version of Prevacid through its subsidiary Matrix Laboratories Co announces that its privately held Indian subsidiary, Matrix Laboratories Limited, has... Briefing.com
- Mylan Receives FDA Approval for Generic Version of Prevacid(R)... 11/10/2009
- PITTSBURGH, Nov. 10 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that its privately held Indian subsidiary, Matrix Laboratories Limited, has received final approval from the... PR Newswire
- Zacks Analyst Blog Highlights: Baker Hughes Inc., BJ Services,... 11/5/2009
- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Business Wire
- Nice Quarter, Teva. What Will You Buy Next? 11/3/2009
- Branded or generic, it's always a tough call. At Motley Fool
- Zacks Analyst Blog Highlights: Bank of America, Citigroup,... 10/30/2009
- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Business Wire
- It's Not as Frightening As It First Appears 10/30/2009
- Warning: generic adjustments ahead. At Motley Fool
- UPDATE 4-Mylan 3rd-qtr results top estimates; shares rise 10/29/2009
- ... At Thomson Reuters
- Mylan results top estimates; shares rise 10/29/2009
- ... At Thomson Reuters
- Mylan reports 3Q loss on revenue drop, charge 10/29/2009
- PITTSBURGH (AP) - Generic drugmaker Mylan Inc. said Thursday it posted a loss during the third quarter on a mix of lower revenue and costs for a legal settlement. Associated Press
- More News
- Market Report
- News by Symbol
- Today's Investing Articles
- Breaking News
- News by Topic
- News by Industry
- MSNBC News
- Data providers
- Copyright © 2009 Thomson Reuters. Click for Restrictions.
- Quotes supplied by Interactive Data Real-Time Services.